empty
 
 
sp
Búsqueda
Soporte
Apertura instantánea de la cuenta
Plataforma comercial
Depositar/Retirar
Búsqueda
Para Principiantes Para Operadores Para Socios Haga una pausa Sobre InstaSpot
sp
#ALNY Voltar para a lista de instrumentos #AUPH

Conversor de moeda

Amgen Inc.
317.47 USD
12 Dec 2025 22:59
Alterar preço (% chg)
$-0.18
(-0.06%)
Fechamento anterior
Fechamento anterior

Preço de fechamento, dia anterior.
$317.67
Abrir
Abrir

Preço de abertura.
$316.36
Alta do dia
Alta do dia

O preço mais alto durante o último dia de negociação.
$319.32
Baixa do dia
Baixa do dia

O preço mais baixo durante o último dia de negociação
$315.06
Alta 52-semanas
Alta 52-semanas

Alta no intervalo De preço das últimas 52 semanas
$345.74
Baixa 52-semanas
Baixa 52-semanas

Baixa no intervalo De preço das últimas 52 semanas
$315.06
Download do arquivo
Comprar
317.47
Vender
317.47
Abra el gráfico en pantalla completa
Comprar
317.47
Vender
317.47
Download do arquivo
Abra el gráfico en pantalla completa

About Amgen Inc.

Amgen Inc. is one of the world's leading biotechnology companies. Founded in 1980 in the United States, it currently operates in more than 70 countries around the world.

Amgen focuses on developing cutting-edge medicines against cancer, cardiovascular diseases, bone ailments, kidney diseases and other afflictions.

The company currently has a market capitalization of $122.5 billion. Amgen reported revenues of $25.98 billion and a net income of $5.89 billion in 2021.

Amgen Inc. stock and what affects it

The company stock is listed on the NASDAQ exchange under the ticker name AMGN. When the company had its initial public offering in 1983, its shares were priced between $16 and $19 at the time.

Now, Amgen's shares are trading between $227 and $231. Last year, it fluctuated from $198 to $258. Forecasts suggest the stock will continue to climb.

When trading this asset, you have to keep the following things in mind:

  • The company has a dominant position in the market.
  • There are potential opportunities to capitalize on its products and strategic initiatives.
  • Threats to Amgen include its competition, government regulation, and the company’s dependence on wholesale distributors.

¿No puede hablar ahora mismo?
Ingrese su pregunta en el chat.